Grow Therapy Raises $150M in Series D Funding

It asks people to navigate a maze of disconnected providers, insurance gaps, and long waitlists. So we set out to clear the pathway to effective care by breaking down those barriers. 

Today, I’m excited to share a meaningful milestone in that journey.

Grow Therapy has raised a $150 million Series D, led by TCV and Growth Equity at Goldman Sachs Alternatives, who led our Series B and C respectively. New investors BCI and Menlo Ventures join existing investors Sequoia, SignalFire, and Transformation Capital.

This round is the direct result of what we’re seeing every day: health plans, employers, and health systems are choosing Grow as a partner to deliver high-quality, affordable mental healthcare to people who need it.

Read More - NODA AI Raises $25M in Series A Funding